drugset / Trial / NCT00666575

A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional Sleeplessness

NCT00666575

Phase 3 Completed 2105 enrolled Viatris Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess the safety of gabapentin, as compared to placebo, in a potential over-the-counter population with reports of occasional sleeplessness

Timeline

Start
2004-12
Primary completion
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 500 mg Oral

Indications